- Home
- SMBK vs SIGA Comparison
SMBK vs SIGA Comparison
Compare SMBK & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBK
- SIGA
- Stock Information
- Founded
- SMBK N/A
- SIGA 1995
- Country
- SMBK United States
- SIGA United States
- Employees
- SMBK N/A
- SIGA N/A
- Industry
- SMBK Major Banks
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- SMBK Finance
- SIGA Health Care
- Exchange
- SMBK Nasdaq
- SIGA Nasdaq
- Market Cap
- SMBK 553.9M
- SIGA 515.1M
- IPO Year
- SMBK N/A
- SIGA 1997
- Fundamental
- Price
- SMBK $33.23
- SIGA $6.46
- Analyst Decision
- SMBK Buy
- SIGA
- Analyst Count
- SMBK 4
- SIGA 0
- Target Price
- SMBK $37.25
- SIGA N/A
- AVG Volume (30 Days)
- SMBK 55.9K
- SIGA 339.6K
- Earning Date
- SMBK 07-21-2025
- SIGA 08-05-2025
- Dividend Yield
- SMBK 0.96%
- SIGA 9.29%
- EPS Growth
- SMBK 62.51
- SIGA N/A
- EPS
- SMBK 2.47
- SIGA 0.67
- Revenue
- SMBK $178,959,000.00
- SIGA $120,330,310.00
- Revenue This Year
- SMBK $22.41
- SIGA N/A
- Revenue Next Year
- SMBK $10.59
- SIGA $95.31
- P/E Ratio
- SMBK $13.46
- SIGA $9.63
- Revenue Growth
- SMBK 20.51
- SIGA N/A
- 52 Week Low
- SMBK $25.58
- SIGA $4.95
- 52 Week High
- SMBK $37.72
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- SMBK 38.31
- SIGA 42.33
- Support Level
- SMBK $35.29
- SIGA $6.97
- Resistance Level
- SMBK $35.67
- SIGA $7.32
- Average True Range (ATR)
- SMBK 0.84
- SIGA 0.21
- MACD
- SMBK -0.38
- SIGA -0.07
- Stochastic Oscillator
- SMBK 0.74
- SIGA 7.53
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.